Rutgers University just says no to growing pot for NJ’s new medical marijuana initiative
Rutgers just says no to pot growing for NJ Correction: Pfizer-Drug Failure story
Correction: Pfizer-Drug Failure story TRENTON, N.J. — In a July 19 story about drugmaker Pfizer Inc. halting a study of an experimental pain drug, The Associated Press reported erroneously that patients have been told to stop taking their pills. The drug, called tanezumab, is an injected medicine. Drugmaker Merck says it will fight $8 million compensatory damages verdict in Fosamax trial more images Pfizer: Study finds high Lipitor dose cuts chances of heart complications over low dose more images Merck: Safety board decides study of Vytorin cholesterol pill’s effectiveness should continue more images Indian American doctor is New Jersey health chiefTRENTON - New Jersey’s Republican Governor Chris Christie has named an Indian American doctor, Poonam Alaigh, as the commissioner of the state Health and Senior Services Department, a cabinet post. Drugmaker Pfizer to focus on 6 research priorities, dump 100 compounds, as it integrates Wyeth more images NJ’s outgoing governor signs medical marijuana bill into law on his last full day in officemore images J&J, foundation to start testing of artificial pancreas in insulin-dependent diabetics
J&J, charity to start testing artificial pancreas Britain’s GlaxoSmithKline pulls application to sell enlarged prostate drug for blocking cancer
Pfizer closing some research plants, consolidating others and cutting staff after buying Wyeth more images Merck, now the world’s No. 2 drugmaker with Schering-Plough purchase, set for future deals more images Fla. man accused of killing ex-son-in-law in NJ to tell jurors he was too fat to kill more images Drugmaker Merck posts slight rise in 3Q sales, but big profit jump due to animal health saleMerck posts big profit jump, slight rise in sales TRENTON, N.J. — Drugmaker Merck & Co. on Thursday posted a bigger profit in the third quarter due to slightly higher sales and a huge gain from selling a business. Drugmaker Bristol-Myers posts higher 3Q sales, but lower profit due to $2B gain a year agoBristol-Myers posts higher 3Q sales, lower profit TRENTON, N.J. — Drugmaker Bristol-Myers Squibb Co. on Thursday reported a solid increase in third-quarter revenue, due to strong sales growth for its blockbuster blood thinner Plavix and other key medicines, and boosted its profit forecast. Merck 3Q earnings report comes as it works to close its $41 billion buyout of Schering-PloughEarnings Preview: Merck to report 3Q earnings TRENTON, N.J. — Merck & Co., a Dow component and the world’s eighth-biggest drug maker by revenue, reports earnings for the third quarter on Thursday morning. The following is a summary of key developments and analyst opinion related to the period. Drugmaker Pfizer’s 3Q profit jumps 26 percent on cost cuts; more expected with Wyeth deal donePfizer 3Q profit jumps 26 percent on cost cutting TRENTON, N.J. — Drugmaker Pfizer Inc. on Tuesday posted a 26 percent jump in third-quarter profit despite the recession, as sharp cost cuts made up for a dip in sales. Drugmaker Merck for first time discloses payments to doctors who give talks to colleaguesMerck starts revealing payments to doctor-speakers TRENTON, N.J. — Merck & Co. paid doctors and nurses a total of $3.7 million this summer to give talks to colleagues about the drugmaker’s products and other health topics, Merck disclosed Monday. Pfizer on track for speedy pruning, alignment of research programs post Wyeth acquisitionPfizer on track for speedy research alignment TRENTON, N.J. — Megamergers in the pharmaceutical industry usually take many months to sort out, but the two research directors at newly combined Pfizer Inc. and Wyeth say they’re off to a running start. Drugmaker Pfizer closes $68B purchase of Wyeth, gets biotech, vaccine, consumer businessesDrugmaker Pfizer closes $68B acquisition of Wyeth TRENTON, N.J. — Pfizer Inc. and Wyeth have tied the knot in the drug industry’s most expensive marriage this year. Recession cuts Johnson & Johnson drug, devices and consumer products sales, profit edges upJ&J ekes out profit rise despite sales drop TRENTON, N.J. — Band-Aid maker Johnson & Johnson is feeling the pain as consumers worldwide buy more generic health products — whether it’s prescription medicines or store-brand bandages — or just do without for as long as they can. Drug, device maker Johnson & Johnson posts 1 percent rise in 3Q profit despite lower salesJ&J posts 1 percent profit rise despite sales drop TRENTON, N.J. — Johnson & Johnson on Tuesday reported a meager 1 percent increase in third-quarter profit, as intensifying generic competition slashed sales of blockbuster prescription drugs. In addition, the global recession hurt consumer product sales and slowed growth for medical devices, the only J&J segment not declining. GlaxoSmithKline bans political donations, alters spending rules on doctor training, consultingGlaxoSmithKline changes doctor training policy TRENTON, N.J. — British drugmaker GlaxoSmithKline PLC said Monday it is making major changes in its funding of educational programs for doctors, reducing the number it sponsors and switching its focus to independent ones with balanced information. Drugmaker Sanofi-Aventis buys Merck’s half of Merial; step needed for Merck to buy ScheringSanofi buys Merck’s half of animal health business TRENTON, N.J. — French drugmaker Sanofi-Aventis SA has completed its $4 billion purchase of Merck & Co.’s half interest in their veterinary medicine business, Merial Ltd., the companies said Friday. Drugmaker Merck, British research charity to develop vaccines for diseases in poor countriesMerck, British charity to jointly develop vaccines TRENTON, N.J. — Drugmaker Merck & Co. and Britain’s largest charity, the Wellcome Trust, said Thursday they are starting a not-for-profit partnership to create affordable vaccines against diseases common in poor countries. NJ urging tests for nearly 5,000 patients in hepatitis B outbreak linked to one doctorNJ: 29 hepatitis cases tied to 1 doctor’s office TRENTON, N.J. — Several thousand patients of a New Jersey doctor should get tested for blood-borne diseases because of an outbreak linked to his office that has led to more than two dozen being diagnosed with hepatitis B, state health officials said. New study finds jobless workers struggling to cope with psychological stress of recessionStudy: unemployed feel ‘traumatized’ by recession TRENTON, N.J. — A new study finds that the recession has left many jobless workers struggling to cope with the psychological stress caused by becoming unemployed in a weak economy. |
Latest TweetsTrenton
Latest Friend FeedsTrenton
|
